Evolution of cell therapy for renal cell carcinoma

Evolution of cell therapy for renal cell carcinoma

Abstract Treatment for renal cell carcinoma (RCC) has improved dramatically over the last decade, shifting from high-dose cytokine therapy in combination with surgical resection of tumors to targeted therapy, immunotherapy, and combination therapies. However, curative treatment, particularly for adv...

Full description

Bibliographic Details
Main Authors: Yufei Wang, Eloah Rabello Suarez, Gabriella Kastrunes, Najla Santos Pacheco de Campos, Rabia Abbas, Renata Schmieder Pivetta, Nithyassree Murugan, Ghanbar Mahmoodi Chalbatani, Vincent D’Andrea, Wayne A. Marasco
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Molecular Cancer
Subjects:
Immunotherapy
Cell therapy
Renal cell carcinoma (RCC)
CAR-T
CAR-NK
Online Access:https://doi.org/10.1186/s12943-023-01911-x

Internet

https://doi.org/10.1186/s12943-023-01911-x

Similar Items